RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > FDA Regulatory Requirements for Botanical INDs

FDA Regulatory Requirements for Botanical INDs

Posted 01 August 2009 | By

The notion of plants as sources of healing is as old as medicine itself. Many valuable drugs used today were adopted through the study of traditional medicines and natural products, which may be used directly or after chemical modification. Medical research shows that using individual ingredients alone may not be as effective as combining them in a formula. It also shows that herbal formulas containing multiple active ingredients can offer solutions to complex problems within a single pill, with synergy of the ingredients occurring inside the body.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.